120 related articles for article (PubMed ID: 28161498)
1. Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic area.
Liang H; Xiang YQ; Lv X; Xie CQ; Cao SM; Wang L; Qian CN; Yang J; Ye YF; Gan F; Ke LR; Yu YH; Liu GY; Qiu WZ; Huang XJ; Wen CH; You N; Wang XQ; Guo X; Xia WX
Eur J Cancer; 2017 Mar; 73():48-60. PubMed ID: 28161498
[TBL] [Abstract][Full Text] [Related]
2. Survival impact of radiotherapy interruption in nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
Yao JJ; Zhang F; Gao TS; Zhang WJ; Lawrence WR; Zhu BT; Zhou GQ; Ma J; Wang SY; Sun Y
Radiother Oncol; 2019 Mar; 132():178-187. PubMed ID: 30448002
[TBL] [Abstract][Full Text] [Related]
3. Platinum-based concurrent chemotherapy remains the optimal regimen for nasopharyngeal carcinoma: a large institutional-based cohort study from an endemic area.
Yu Y; Liang H; Lv X; Ke L; Qiu W; Huang X; Liu G; Li W; Guo X; Xiang Y; Xia W
J Cancer Res Clin Oncol; 2018 Nov; 144(11):2231-2243. PubMed ID: 30109501
[TBL] [Abstract][Full Text] [Related]
4. Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States.
Murphy CT; Galloway TJ; Handorf EA; Egleston BL; Wang LS; Mehra R; Flieder DB; Ridge JA
J Clin Oncol; 2016 Jan; 34(2):169-78. PubMed ID: 26628469
[TBL] [Abstract][Full Text] [Related]
5. Induction Chemotherapy Followed by Radiotherapy versus Concurrent Chemoradiotherapy in elderly patients with nasopharyngeal carcinoma: finding from a propensity-matched analysis.
Zeng Q; Wang J; Lv X; Li J; Yin LJ; Xiang YQ; Guo X
BMC Cancer; 2016 Aug; 16(1):693. PubMed ID: 27577729
[TBL] [Abstract][Full Text] [Related]
6. The impact of time factors on overall survival in patients with nasopharyngeal carcinoma: a population-based study.
Chen PC; Liu WS; Huang WL; Wu CJ; Yang CC; Lee CC
Radiat Oncol; 2016 Apr; 11():62. PubMed ID: 27117713
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients.
Liu LT; Chen QY; Tang LQ; Guo SS; Guo L; Mo HY; Chen MY; Zhao C; Guo X; Qian CN; Zeng MS; Bei JX; Tan J; Chen S; Hong MH; Shao JY; Sun Y; Ma J; Mai HQ
Cancer Res Treat; 2018 Jan; 50(1):19-29. PubMed ID: 28392551
[TBL] [Abstract][Full Text] [Related]
9. Risk of hypothyroidism among patients with nasopharyngeal carcinoma treated with radiation therapy: A Population-Based Cohort Study.
Fan CY; Lin CS; Chao HL; Huang WY; Su YF; Lin KT; Tsai IJ; Kao CH
Radiother Oncol; 2017 Jun; 123(3):394-400. PubMed ID: 28532605
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal carcinoma: 30-year experience of a single institution in a non-endemic area.
García-Lorenzo J; Farre N; Codina A; Gallego O; De Vega M; León X
Clin Transl Oncol; 2017 Jun; 19(6):777-783. PubMed ID: 28120323
[TBL] [Abstract][Full Text] [Related]
11. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment.
Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X
Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862
[TBL] [Abstract][Full Text] [Related]
12. A new prognostic histopathologic classification of nasopharyngeal carcinoma.
Wang HY; Chang YL; To KF; Hwang JS; Mai HQ; Feng YF; Chang ET; Wang CP; Kam MK; Cheah SL; Lee M; Gao L; Zhang HZ; He JH; Jiang H; Ma PQ; Zhu XD; Zeng L; Chen CY; Chen G; Huang MY; Fu S; Shao Q; Han AJ; Li HG; Shao CK; Huang PY; Qian CN; Lu TX; Li JT; Ye W; Ernberg I; Ng HK; Wee JT; Zeng YX; Adami HO; Chan AT; Shao JY
Chin J Cancer; 2016 May; 35():41. PubMed ID: 27146632
[TBL] [Abstract][Full Text] [Related]
13. Benefits of local tumor excision and pharyngectomy on the survival of nasopharyngeal carcinoma patients: a retrospective observational study based on SEER database.
Sun J; Huang Z; Hu Z; Sun R
J Transl Med; 2017 May; 15(1):116. PubMed ID: 28558725
[TBL] [Abstract][Full Text] [Related]
14. Influence of pretreatment ideal body weight percentile and albumin on prognosis of nasopharyngeal carcinoma: Long-term outcomes of 512 patients from a single institution.
Li G; Gao J; Liu ZG; Tao YL; Xu BQ; Tu ZW; Zhang XP; Zeng MS; Xia YF
Head Neck; 2014 May; 36(5):660-6. PubMed ID: 23606535
[TBL] [Abstract][Full Text] [Related]
15. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: Clinical implications for prognosis and treatment.
Xu P; Min Y; Blanchard P; Feng M; Zhang P; Luo Y; Fan Z; Lang J
Head Neck; 2017 Feb; 39(2):305-310. PubMed ID: 27627795
[TBL] [Abstract][Full Text] [Related]
16. Metastatic nasopharyngeal carcinoma: Patterns of care and survival for patients receiving chemotherapy with and without local radiotherapy.
Rusthoven CG; Lanning RM; Jones BL; Amini A; Koshy M; Sher DJ; Bowles DW; McDermott JD; Jimeno A; Karam SD
Radiother Oncol; 2017 Jul; 124(1):139-146. PubMed ID: 28433411
[TBL] [Abstract][Full Text] [Related]
17. The detrimental effects of radiotherapy interruption on local control after concurrent chemoradiotherapy for advanced T-stage nasopharyngeal carcinoma: an observational, prospective analysis.
Yao JJ; Jin YN; Wang SY; Zhang F; Zhou GQ; Zhang WJ; Zhi-Bin ; Cheng ; Ma J; Qi ZY; Sun Y
BMC Cancer; 2018 Jul; 18(1):740. PubMed ID: 30012115
[TBL] [Abstract][Full Text] [Related]
18. Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.
Lee VH; Lo AW; Leung CY; Shek WH; Kwong DL; Lam KO; Tong CC; Sze CK; Leung TW
PLoS One; 2016; 11(6):e0157969. PubMed ID: 27341634
[TBL] [Abstract][Full Text] [Related]
19. Modified-Nutrition Index is a Significant Prognostic Factor for the Overall Survival of the Nasopharyngeal Carcinoma Patients who Undergo Intensity-modulated Radiotherapy.
Hong JS; Hua YJ; Su L; Zhang HR; Lv WL; Chen XY; Tian J; Zhang WJ
Nutr Cancer; 2017 Oct; 69(7):1011-1018. PubMed ID: 28937797
[TBL] [Abstract][Full Text] [Related]
20. Use of pretreatment serum uric acid level to predict metastasis in locally advanced nasopharyngeal carcinoma.
Du XJ; Chen L; Li WF; Tang LL; Mao YP; Guo R; Sun Y; Lin AH; Ma J
Head Neck; 2017 Mar; 39(3):492-497. PubMed ID: 27997061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
